Gameday Men's Health Memphis TRT and ED Clinic
- PRP Therapy
- Shockwave Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
Memphis, TN
Memphis has a regional medical hub with Methodist and Baptist hospital systems, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across East Memphis, Germantown, and Collierville range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Methodist Le Bonheur, Baptist Memorial, and Regional One network. The scene here skews toward clinics serving a mixed demographic at Mid-South price points. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Memphis clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Regulatory context
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
The Tennessee Board of Pharmacy inspects compounding facilities for USP compliance. Non-resident pharmacies shipping peptides into Tennessee must hold a current non-resident permit. Given Tennessee's active medical spa and wellness clinic sector, the Board monitors peptide sourcing and sterile compounding practices closely.